Advertise with us
Read Magazine Self Publish Advertise
Send news Online ads Get Interviewed
EYES INTM Health: News from the World's Innovative Creators & Their Masterpieces | Friday, April 25, 2014
Sign up for our Newsletter!

All newsletter emails are double opt in, you must confirm your email or make a purchase to receive news from us, if you want to be removed from our mailing list please click the "unsubscribe" button on the email you received. (privacy policy)
Sign up for the Health Newsletter



All newsletter emails are double opt in, you must confirm your email or make a purchase to receive news from us, if you want to be removed from our mailing list please click the "unsubscribe" button on the email you received. (privacy policy)

CANCEL YOUR NEWSLETTER SUBSCRIPTION.

(note: this will not cancel paid digital edition or advertising subscriptions.)

EMAIL:

ONCOblot: Power to Catch Cancer's Earliest Stage

USA- Dallas, TX | Mar 20 2013 | (22:51:51 - EDT)

ONCOblot® Test, a highly sensitive blood test for cancer, is now available for use by physicians across the United States; bringing much needed support to the phrase “early detection is key”.

The ONCOblot® Test, one of the latest test for cancer, was developed by Mor-NuCo in West Lafayette, Indiana, ONCOblot® is a Laboratory Developed Test, CLIA and CAP accredited, and has the power to catch all forms of known cancer at their absolute earliest stage of detection.

The test works by locating and identifying the ENOX 2 proteins in the blood, which are unique to malignant cancer cells. Based on the type of ENOX 2 protein identified, the ONCOblot® Test reveals the host site organ, and stage of cancer.

Advertise with us

“Our test is the most sensitive blood test for cancer available today,” says ONCOblot® Test researcher and developer, Dr. Jim Morre’, CEO and Director of Research, Mor-NuCo, LLC. “ONCOblot® detects a cancer of 2 million cells compared to 4.5 trillion cells in a positive mammogram,” he continued.

In addition to the basic function of identifying the presence of cancer, the ONCOblot® Test also screens for origin of cancer, recurrence of cancer, familial cancer, and the presence of malignant cells while undergoing treatments for cancer.

ONCOblot® Test, one of the latest blood tests for cancer, is a key component to treating cancer because it gives patients and physicians the insights for successful cancer management. Never before has one test been able to detect cancer on such a micro level and provide so much knowledge for early intervention and on-going management.

About ONCOblot®

The ONCOblot® Test was developed and created by Dr. D. James Morre’ and Dr. Dorothy M. Morre’ of Mor-NuCo, Purdue Research Park, West Lafayette, IN. The Morre’s are committed to the premise that understanding cancer is the key to its conquest. The ONCOblot® test is based on more than 20 years of basic research.

Source: ONCOblot Labs

For more on innovative health solutions, subscribe to EYESIN.com.

Share it:

Reactions

Leave a Reply

Archive:
Links:
  • Google search the internet giant
  • Wahooart museum Most famous Paintings of all time. Wahooart museum offers hand painted fine art reproductions.
Advertise with us
Advertisement- (place your ad here)
Valid CSS! Valid HTML 5.0 (experimental) Valid CSS!
Copyright © EYES IN™ Corp 2012. All Rights Reserved. | Contact us | Privacy Policy | Terms of use
Website by Redfish Creative